Peptides derived from snake venom nerve growth factors can … – Department Of Science & Technology

Related Articles:

• Forget Special K, maybe focus on LysoK February 20, 2021 # # # # Over the last 20 years, researchers have identified a number of genetic variations that can confer an increased risk of developing Parkinson’s. Tiny alterations in regions of DNA (called genes) – which provide the instructions for making a protein – can increase one’s chances of Parkinson’s. A better understanding of the biological pathways associated with these…
• The road ahead: 2022 January 20, 2022 # # # # The first post at the start of each year on the SoPD website tries to provide an overview of where things are in the search for ‘disease modifying’ therapies for Parkinson’s.  It is an exercise in managing expectations as well as discussing what research events are scheduled for the next year so that we can keep…
• The road ahead: 2021 January 25, 2021 # # # # At the start of each year, it is a useful practise to layout what is planned over the next 12 months. The events that are scheduled for the year to come, so that we can keep an eye out for them. Obviously, where 2021 will end actually is unpredictable, but an outline of what is scheduled…
• Synucleinopathy begets channelopathy? March 20, 2021 # # # # Alpha synuclein is a protein that is closely associated with Parkinson’s. It was the first gene to be associated with increased risk of developing Parkinson’s, and the alpha synuclein protein was found to be present in Lewy bodies – a characteristic feature of the Parkinson’s brain. As a result of this association, researcher have used high…
• A rising tide with liraglutide April 18, 2022 # # # # A class of diabetes drugs called GLP-1 receptor agonists have exhibited neuroprotective properties in models of Parkinson’s, and a Phase IIb clinical trial produced encouraging. This research has led to a number of parties to start investigating new and old GLP-1 receptor agonists for their potential to slow the progression of Parkinson’s. Recently, the results of…
• Peptide based therapy for neurological disorders September 21, 2021 Curr Protein Pept Sci. 2021 Sep 20. doi: 10.2174/1389203722666210920151810. Online ahead of print.ABSTRACTPeptides are small molecules composed of amino acids linked together by peptide bonds. The targeted action of these peptides along with their magnificent ability to reach locations in body that are complicated to access, is being considered of tremendous potential in disease modifying therapies. Synthetic as well as…
• Peptide based therapy for neurological disorders September 21, 2021 Curr Protein Pept Sci. 2021 Sep 20. doi: 10.2174/1389203722666210920151810. Online ahead of print.ABSTRACTPeptides are small molecules composed of amino acids linked together by peptide bonds. The targeted action of these peptides along with their magnificent ability to reach locations in body that are complicated to access, is being considered of tremendous potential in disease modifying therapies. Synthetic as well as…
• Peptide based therapy for neurological disorders September 21, 2021 Curr Protein Pept Sci. 2021 Sep 20. doi: 10.2174/1389203722666210920151810. Online ahead of print.ABSTRACTPeptides are small molecules composed of amino acids linked together by peptide bonds. The targeted action of these peptides along with their magnificent ability to reach locations in body that are complicated to access, is being considered of tremendous potential in disease modifying therapies. Synthetic as well as…
• Peptide based therapy for neurological disorders September 21, 2021 Curr Protein Pept Sci. 2021 Sep 20. doi: 10.2174/1389203722666210920151810. Online ahead of print.ABSTRACTPeptides are small molecules composed of amino acids linked together by peptide bonds. The targeted action of these peptides along with their magnificent ability to reach locations in body that are complicated to access, is being considered of tremendous potential in disease modifying therapies. Synthetic as well as…
• Peptide based therapy for neurological disorders September 21, 2021 Curr Protein Pept Sci. 2021 Sep 20. doi: 10.2174/1389203722666210920151810. Online ahead of print.ABSTRACTPeptides are small molecules composed of amino acids linked together by peptide bonds. The targeted action of these peptides along with their magnificent ability to reach locations in body that are complicated to access, is being considered of tremendous potential in disease modifying therapies. Synthetic as well as…
• Monthly Research Review – January 2021 January 31, 2021 # # # # At the end of each month the SoPD writes a post which provides an overview of some of the major pieces of Parkinson’s-related research that were made available during the previous 4 weeks. The post is divided into eight parts based on the type of research: Basic biology Disease mechanism Clinical research New clinical trials Clinical…
• New Way of Manipulating Stem Cells Leads to Healthy Nerve Cells in Animal Study May 28, 2020 Scientists have created a special matrix that allowed them to differentiate stem cells into nerve cells that, when transplanted into a rat model of Parkinson’s disease, eased the animals’ symptoms by replacing those nerve cells lost to the disease. This matrix is also able to stimulate differentiation of stem cells, prodding them to become nerve cells, without a need for…
• New Way of Manipulating Stem Cells Leads to Healthy Nerve Cells in Animal Study May 28, 2020 Scientists have created a special matrix that allowed them to differentiate stem cells into nerve cells that, when transplanted into a rat model of Parkinson’s disease, eased the animals’ symptoms by replacing those nerve cells lost to the disease. This matrix is also able to stimulate differentiation of stem cells, prodding them to become nerve cells, without a need for…
• New Way of Manipulating Stem Cells Leads to Healthy Nerve Cells in Animal Study May 28, 2020 Scientists have created a special matrix that allowed them to differentiate stem cells into nerve cells that, when transplanted into a rat model of Parkinson’s disease, eased the animals’ symptoms by replacing those nerve cells lost to the disease. This matrix is also able to stimulate differentiation of stem cells, prodding them to become nerve cells, without a need for…
• Patients not patents February 13, 2022 # # # # Patent protection provides an inventor/discoverer with an exclusive right to prevent or stop others from commercially exploiting the patented invention for a set period of time. Patents are supposed to encourage innovation by providing the patent holder with an unchallenged opportunity to develop and profit from an idea. But it could be argued that patents are…
• The Brilliant 10: The top up-and-coming minds in science October 19, 2022 Popular Science There’s a phrase that rings loudly in the heads of Popular Science editors any time we bring together a new Brilliant 10 class: “They’ve only just begun.” Our annual list of early-career scientists and engineers is as much a celebration of what our honorees have already accomplished as it is a forecast for what they’ll do next. To…
• Breathtaking research April 24, 2022 # # # # Breathing is one of those many aspects of life that we all take completely for granted for the vast majority of our time on planet Earth. It represents not only a magnificent means of providing our bodies with oxygen, but also disposing of waste. Recently researchers have attempted to see if there are any components in…
• Monthly Research Review – October 2021 October 31, 2021 # # # # At the end of each month the SoPD writes a post which provides an overview of some of the major pieces of Parkinson’s-related research that were made available during October 2021. The post is divided into 10 parts based on the type of research: Top 5 pieces of Parkinson’s news Articles of general interest Basic biology…
• The Bluerockers have started July 15, 2021 # # # # On the 8th June, BlueRock Therapeutics put out a press release announcing that the first participant in their Phase I clinical trial of cell transplantation for Parkinson’s had been dosed (Click here to read the press release). The initiation of this clinical trial by the company is a major step forward for them and for the…
• Bee Venom Does Not Reduce the Risk for Parkinson's Disease: Epidemiological Study among Beekeepers October 16, 2021 Mov Disord. 2021 Oct 16. doi: 10.1002/mds.28820. Online ahead of print.ABSTRACTBACKGROUND: Based on the promising results from preclinical studies, bee venom has been investigated as a neuroprotective agent in Parkinson's disease.OBJECTIVE: To assess if longstanding exposure to bee venom is associated with decreased risk for Parkinson's disease among beekeepers.METHODS: Questionnaire gathering information about diagnosis of Parkinson's disease and exposure to…
• Bee Venom Does Not Reduce the Risk for Parkinson's Disease: Epidemiological Study among Beekeepers October 16, 2021 Mov Disord. 2021 Oct 16. doi: 10.1002/mds.28820. Online ahead of print.ABSTRACTBACKGROUND: Based on the promising results from preclinical studies, bee venom has been investigated as a neuroprotective agent in Parkinson's disease.OBJECTIVE: To assess if longstanding exposure to bee venom is associated with decreased risk for Parkinson's disease among beekeepers.METHODS: Questionnaire gathering information about diagnosis of Parkinson's disease and exposure to…
• Bee Venom Does Not Reduce the Risk for Parkinson's Disease: Epidemiological Study among Beekeepers October 16, 2021 Mov Disord. 2021 Oct 16. doi: 10.1002/mds.28820. Online ahead of print.ABSTRACTBACKGROUND: Based on the promising results from preclinical studies, bee venom has been investigated as a neuroprotective agent in Parkinson's disease.OBJECTIVE: To assess if longstanding exposure to bee venom is associated with decreased risk for Parkinson's disease among beekeepers.METHODS: Questionnaire gathering information about diagnosis of Parkinson's disease and exposure to…